Samuel Levy

Chief Tech/Sci/R&D Officer at ClearNote Health, Inc.

Health Technology

Consumer Services

Profile

Samuel Levy is currently the Chief Scientific Officer at ClearNote Health, Inc. He previously held the position of Chief Scientific Officer at Genomic Health, Inc. Dr. Levy completed his undergraduate degree at the University of Leeds and obtained a doctorate degree from the University of Bristol.

Samuel Levy active positions

Companies	Position	Start
ClearNote Health, Inc. ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022.	Chief Tech/Sci/R&D Officer	-

All active positions of Samuel Levy

Former positions of Samuel Levy

Companies	Position	End
GENOMIC HEALTH, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Samuel Levy's experience

Training of Samuel Levy

University of Leeds	Undergraduate Degree
University of Bristol	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Samuel Levy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Genomic Health, Inc. Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.	Health Technology
ClearNote Health, Inc. ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022.	Health Technology